GNAS-AS1: A Protein Implicated in Various Diseases (G149775)

Target Name: GNAS-AS1

NCBI ID: G149775

GNAS-AS1: A Protein Implicated in Various Diseases

GNAS-AS1 (Guanosine adenylate binding protein-AS1) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell signaling pathways, and its dysfunction has been implicated in numerous diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a drug target and biomarker, GNAS-AS1 has significant potential for the development of new therapeutic approaches.

GNAS-AS1 functions as a guanosine analogase, which converts guanosine to guanosine monophosphate (GMP) in a process that regulates protein-protein interactions and cell signaling pathways. GNAS-AS1 is a critical regulator of the negative signaling pathway, which is involved in the regulation of cell proliferation, apoptosis, and inflammation. In this pathway, GNAS-AS1 plays a vital role in the negative regulation of the microtubule dynamics, which is essential for the proper cell division and apoptosis.

GNAS-AS1 has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, GNAS-AS1 has been implicated in the development and progression of neurobladder cancer. Studies have shown that GNAS-AS1 expression is increased in neurobladder cancer tissues compared to normal tissues, and that inhibition of GNAS-AS1 has led to a significant reduction in neurobladder cancer cell proliferation.

Another study has shown that GNAS-AS1 is involved in the development of Alzheimer's disease. The study found that GNAS-AS1 was expressed in the brains of individuals with Alzheimer's disease, and that overexpression of GNAS-AS1 was associated with the development of neuropathological changes in these individuals. Therefore, GNAS-AS1 may be a potential drug target for the treatment of Alzheimer's disease.

In addition to its involvement in neurodegenerative diseases, GNAS-AS1 has also been implicated in the development and progression of cancer. For example, GNAS-AS1 has been shown to be involved in the development and progression of colorectal cancer. Studies have shown that GNAS -AS1 expression is increased in colorectal cancer tissues compared to normal tissues, and that inhibition of GNAS-AS1 has led to a significant reduction in colorectal cancer cell proliferation.

Furthermore, GNAS-AS1 has also been shown to be involved in the development and progression of other diseases, including cardiovascular diseases and autoimmune diseases. For example, GNAS-AS1 has been implicated in the development and progression of heart failure. Studies have shown that GNAS-AS1 expression is increased in heart failure tissues compared to normal tissues, and that inhibition of GNAS-AS1 has led to a significant reduction in heart failure cell proliferation.

In conclusion, GNAS-AS1 is a protein that is involved in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a drug target and biomarker, GNAS-AS1 has significant potential for the development of new therapeutic approaches. Further research is needed to fully understand the role of GNAS-AS1 in disease progression and to develop effective treatments.

Protein Name: GNAS Antisense RNA 1

More Common Targets